211 related articles for article (PubMed ID: 18702503)
1. Inhibition of serine beta-lactamases by vanadate-catechol complexes.
Adediran SA; Pratt RF
Biochemistry; 2008 Sep; 47(36):9467-74. PubMed ID: 18702503
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
Nagarajan R; Pratt RF
Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of serine amidohydrolases by complexes of vanadate with hydroxamic acids.
Bell JH; Curley K; Pratt RF
Biochem Biophys Res Commun; 2000 Aug; 274(3):732-5. PubMed ID: 10924345
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of the beta-lactamase of Enterobacter cloacae P99 by 1:1 complexes of vanadate with hydroxamic acids.
Bell JH; Pratt RF
Biochemistry; 2002 Apr; 41(13):4329-38. PubMed ID: 11914079
[TBL] [Abstract][Full Text] [Related]
5. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
Perumal SK; Adediran SA; Pratt RF
Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates.
Kaur K; Adediran SA; Lan MJ; Pratt RF
Biochemistry; 2003 Feb; 42(6):1529-36. PubMed ID: 12578365
[TBL] [Abstract][Full Text] [Related]
7. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
Usher KC; Blaszczak LC; Weston GS; Shoichet BK; Remington SJ
Biochemistry; 1998 Nov; 37(46):16082-92. PubMed ID: 9819201
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of class D beta-lactamases by diaroyl phosphates.
Majumdar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2005 Dec; 44(49):16121-9. PubMed ID: 16331972
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling of Henry-Michaelis and acyl-enzyme complexes between imipenem and Enterobacter cloacae P99 beta-lactamase.
Fenollar-Ferrer C; Donoso J; Frau J; Muñoz F
Chem Biodivers; 2005 May; 2(5):645-56. PubMed ID: 17192008
[TBL] [Abstract][Full Text] [Related]
12. Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases.
Tsang WY; Ahmed N; Hinchliffe PS; Wood JM; Harding LP; Laws AP; Page MI
J Am Chem Soc; 2005 Dec; 127(49):17556-64. PubMed ID: 16332108
[TBL] [Abstract][Full Text] [Related]
13. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
[TBL] [Abstract][Full Text] [Related]
14. Metallic nanoparticles bioassay for Enterobacter cloacae P99 beta-lactamase activity and inhibitor screening.
Liu R; Teo W; Tan S; Feng H; Padmanabhan P; Xing B
Analyst; 2010 May; 135(5):1031-6. PubMed ID: 20419253
[TBL] [Abstract][Full Text] [Related]
15. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
[TBL] [Abstract][Full Text] [Related]
16. The relative catalytic efficiency of beta-lactamase catalyzed acyl and phosphyl transfer.
Slater MJ; Laws AP; Page MI
Bioorg Chem; 2001 Apr; 29(2):77-95. PubMed ID: 11300697
[TBL] [Abstract][Full Text] [Related]
17. Kinetic study of two novel enantiomeric tricyclic beta-lactams which efficiently inactivate class C beta-lactamases.
Vilar M; Galleni M; Solmajer T; Turk B; Frère JM; Matagne A
Antimicrob Agents Chemother; 2001 Aug; 45(8):2215-23. PubMed ID: 11451677
[TBL] [Abstract][Full Text] [Related]
18. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and structural consequences of the leaving group in substrates of a class C beta-lactamase.
Ahn YM; Pratt RF
Bioorg Med Chem; 2004 Mar; 12(6):1537-42. PubMed ID: 15018927
[TBL] [Abstract][Full Text] [Related]
20. O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site.
Wyrembak PN; Babaoglu K; Pelto RB; Shoichet BK; Pratt RF
J Am Chem Soc; 2007 Aug; 129(31):9548-9. PubMed ID: 17628063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
